Curaleaf Holdings (CURLF) Non-Current Debt (2019 - 2025)
Curaleaf Holdings (CURLF) recorded quarterly Non-Current Debt of $512.9 million in Q4 2025, up 9.86% quarter-over-quarter from $466.9 million in Q4 2024, and up 9.86% on a YoY basis from $466.9 million in Q4 2024.
Curaleaf Holdings (CURLF) Non-Current Debt (2019 - 2025) Analysis & Trends
Curaleaf Holdings' Non-Current Debt history runs 7 years deep, the most recent figure standing at $512.9 million for Q4 2025.
- In Q4 2025, Non-Current Debt rose 9.86% year-over-year to $512.9 million; the TTM figure through Dec 2025 stood at $512.9 million (up 9.86% YoY), while the FY2025 annual figure was $512.9 million, up 9.86% from the prior year.
- Non-Current Debt was $512.9 million for Q4 2025 at Curaleaf Holdings, up from $466.9 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $582.0 billion in Q1 2022 to a low of $153.6 million in Q4 2021.
- Historically, Non-Current Debt has averaged $122.9 billion across 5 years, with a median of $512.9 million in 2025.
- Biggest YoY gain for Non-Current Debt was 124217.58% in 2021; the steepest drop was 46.12% in 2021.
- A 5-year view of Non-Current Debt shows it stood at $153.6 million in 2021, then jumped by 271.71% to $570.8 million in 2022, then declined by 3.94% to $548.3 million in 2023, then fell by 14.84% to $466.9 million in 2024, then rose by 9.86% to $512.9 million in 2025.
- The last three Non-Current Debt figures came in at $512.9 million (Q4 2025), $466.9 million (Q4 2024), and $461.5 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 14.02 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 3.92 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.48 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 569.60 Mn |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 512.92 Mn |
| Dec 31, 2025 | 512.92 Mn |
| Dec 31, 2024 | 466.90 Mn |
| Dec 31, 2024 | 466.90 Mn |
| Sep 30, 2024 | 461.48 Mn |
| Sep 30, 2024 | 461.48 Mn |
| Jun 30, 2024 | 460.32 Mn |
| Jun 30, 2024 | 460.32 Mn |
| Dec 31, 2023 | 548.29 Mn |
| Dec 31, 2023 | 548.29 Mn |
| Sep 30, 2023 | 200.44 Mn |
| Sep 30, 2023 | 200.44 Mn |
| Jun 30, 2023 | 211.58 Mn |
| Jun 30, 2023 | 211.58 Mn |
| Dec 31, 2022 | 570.79 Mn |
| Dec 31, 2022 | 570.79 Mn |
| Mar 31, 2022 | 581.98 Bn |
| Mar 31, 2022 | 581.98 Bn |
| Dec 31, 2021 | 153.56 Mn |
| Dec 31, 2021 | 153.56 Mn |